Safety and long-term immunogenicity of the two-dose heterologous Ad26. ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: A combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial
作者： David Ishola , Daniela Manno , Muhammed O Afolabi , Babajide Keshinro , Viki Bockstal
DOI:
关键词:
摘要: … MVA-BN-Filo vaccine regimen, which was assessed in all participants who had received at least one dose of study vaccine… first 7 days after each vaccination, unsolicited adverse events …
参考文章(0)